Various parameters such as early-onset breast cancer, human epidermal growth factor receptor 2 (HER-2) upregulation, high tumor grade, and estrogen receptor negativity (ER-) were identified as independent risk factors for the development of brain metastasis [3,4]. This evidence concerns the gene ERBB2 and breast carcinoma.